BQ Prime’s special research section collates quality and in-depth equity and economy research reports from across India’s top brokerages, asset managers and research agencies. These reports offer BQ Prime’s subscribers an opportunity to expand their understanding of companies, sectors and the economy.
Motilal Oswal Report
Apollo Tyres Ltd. hosted an investor meet followed by the Andhra Pradesh plant visit. The plant has dedicated lines for passenger car radial and truck-bus radial products with a capacity of 15,000 and 3,000 tyres per day, respectively.
Further, as the current facility for TBR/PCR is at the center of the 104 Hectare Greenfield campus, it has a scope to expand both on the left and right directions. Management discussed about its FY26 vision of:
a revenue of $5.0 billion (versus $3.1 billion in FY23),
an Ebitda of more than 15.0% (versus 13.5% in FY23),
a return on capital employed of 12-15% (versus 10.1% in FY23) and
a net debt-to-Ebitda of less than two times (versus 1.4 times in FY23).
While Apollo Tyres indicated that capacities will be added in FY26, the next leg of capex is likely to be prudent and will not be bunched up. Hence, we believe it can be funded from operating cash flows.
Valuation and view:
We have marginally cut our earnings estimates by 1% as Apollo Tyres is likely budget for the next phase of capex starting from FY25. However, unlike in the past, the current phase of capex is going to be brownfield (lower intensity) and would not be bunched up (and hence, manageable from its operating cash flows).
Therefore, we estimate Apollo Tyres to turn net debt free by FY25.
We raise our target multiple for Apollo Tyres to 15 times from 13 times, to factor in the company’s sustained focus on capital allocation and the resultant increase in capital efficiencies (return on capital employed more than 15%).
Click on the attachment to read the full report:
DISCLAIMER
This report is authored by an external party. BQ Prime does not vouch for the accuracy of its contents nor is responsible for them in any way. The contents of this section do not constitute investment advice. For that you must always consult an expert based on your individual needs. The views expressed in the report are that of the author entity and do not represent the views of BQ Prime.
Users have no license to copy, modify, or distribute the content without permission of the Original Owner.
RECOMMENDED FOR YOU

Why Is Apollo Hospitals Stock Poised For Re-Rating? Read PL Capital Report

Mobikwik Shares Continue To Surge, Marks 18% Gain In Two Sessions


Apollo Micro Systems Share Price Up Over 2% Following DRDO Partnership


Multibagger Apollo Micro Systems Shares Hit Life High As Defence Indigenisation Spurs Growth
